40. AMYLOIDOSIS.ppt

rohitshrivastava97 108 views 22 slides Jan 21, 2023
Slide 1
Slide 1 of 22
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22

About This Presentation

amyloidosis


Slide Content

AMYLOIDOSIS
Dept of Pathology
JNMC

Learning Objective
•At the end of the lecture the learner should be
able to:-
1.Define and classify amyloidosis
2.Describe the physical and chemical nature of
amyloidosis
3. Describe the etiopathogenesis and morphology of
amyloidosis

Amyloidosis
•amylum = starch; amyloid = starchlike
•abnormal proteinaceous substance deposited
between cells in many tissues and organs
•intercellular pink translucent material
•variety of clinical disorders

•A. = not a single chemical entity
•two major and several minor biochemical forms
•several pathogeneticallydifferent mechanisms
•unique tertiary structure -ß-pleated sheet
conformation
•responsible for staining properties and for
resistance to enzymes

Chemical nature of amyloid
•two types-
•immunoglobulin light chains -AL (amyloid
light chain)-in B-cell disorders
•nonimmunoglobulinprotein -AA (amyloid
associated)-in chronic inflammations

Classification of amyloidosis
•SYSTEMIC-kidneys, liver, spleen, adrenals,
lymph nodes
•LOCALIZED-various organs

Systemic amyloidosis
1.PRIMARY -IMMUNOCYTE DYSCRASIAS
deposition of AL-A., produced by aberrant clones of B-
cells -most frequent form. in multiple myeloma
monoclonal proliferation (neoplasm) of plasma cells -
monoclonal gammopathy
multiple osteolyticlesions of the bones
in addition to monoclonal Ig-production of isolated
kappa or lambda light chain (Bence-Jones protein)
only 6-15% of patients with MM develop amyloidosis

2. SECONDARY AMYLOIDOSIS
•reactive AA amyloid-protracted breakdown of
cells, usually in chronic inflammatory disorders
•TBC, osteomyelitis, bronchiectasis
•RA, connective tissue disorders, ulcerative
colitis, tumors (Hodgkin's ML)

Localized amyloidosis
•heterogenous group
•nodular deposits -lungs, larynx, skin, urinary
bladder, tongue -infiltration of B-cells -probably
well differentiated plasmacytoma
•special forms:
•AE -endocrine tumors (medullary ca of thyroid)
•AS -senile amyloid (brain, heart)

Staining of amyloid
Gross reactions
Virchow I. -staining by Lugol'ssol.
Virchow II. -reaction with H
2
SO
4
Microscopy
Hematoxylinand Eosin (HE) staining results in amorphous
eosinophilicappearancewhen viewed on light
microscopy.
metachromasia(cresylviolet, gentian violet)
Congo red -green birefringence
monoclonal antibodies against different types of amyloid-
more precise classification

Congo red staining of a cardiac biopsy specimen
containing amyloid, viewed under polarized light

Involvement of organs
Kidneys
most common, most serious
glomeruli, vessels, peritubularstroma
nephroticsyndrome
Spleen
two types -follicular (sago) and diffuse (lardaceous) spleen

Liver
weight up to 9kg!
space of Disse-atrophy of hepatocytes
Heart
AS-amyloid-left atrium (ANF granules)
AA -in systemic involvement -firm, wax-like

Amorphous eosinophilic interstitial amyloid
observed on renal biopsy

CARDIAC AMYLOID

Liver amyloid

Clinical symptomatology
•incidental finding at autopsy
•severe clinical symptoms -renal malfunctions,
hepatosplenomegaly, heart involvement
•Dx.: needle biopsy of lesion; in systemic -
biopsy of rectal or oral mucosa

SUMMARY
Can affect any organ system , classify
Hematoxylinand Eosin (HE) and Congo stain only
tells you these are amyloidfibrils
Need to immunostainto determine subtype

References
•Harsh Mohan . Textbook of Pathology, 6
th
Ed.
2010
•Robbins and Cotran. Pathologic Basis of
Disease

THANK YOU
Tags